Related Experiment Video
Updated: Jan 15, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
A simple formula for predicting the warfarin dose in atrial fibrillation: development, external validation, and model
Anunya Ujjin1,2, Natnicha Pongbangli3, Wanwarang Wongcharoen4
1Division of Medicine, Neurological Institute of Thailand, Bangkok, Thailand.
A new, simple warfarin dosing formula using age, weight, and creatinine levels helps prevent overdosing in high-risk patients. This practical tool aids clinicians in safely managing warfarin therapy, especially for those with atrial fibrillation.
Area of Science:
- Pharmacology
- Clinical Medicine
- Drug Dosing
Background:
- Warfarin dosing is highly individualized.
- Existing prediction formulas are often complex and impractical for routine clinical use.
Purpose of the Study:
- To identify predictors of warfarin maintenance dosage.
- To develop a simplified warfarin dosing formula.
- To identify high-risk atrial fibrillation patients prone to bleeding without pharmacogenetic data.
Main Methods:
- Retrospective cohort study (2011-2021).
- Development of a first-order equation for warfarin dose prediction.
- Validation in separate training and testing cohorts with target INR of 2.0-3.0.
Main Results:
- A formula was developed: 3 + (0.02 × body weight) - (0.02 × age) - (0.4 × serum creatinine).
- The formula identified increased overdose risk in patients with low body weight, advanced age, or reduced eGFR.
- Validation cohort results confirmed the formula's performance.
Conclusions:
- A straightforward warfarin dosing formula incorporating age, body weight, and serum creatinine effectively reduces overdose risk.
- This formula is particularly beneficial for managing high-risk patient populations, including those with atrial fibrillation.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Estimation of k and VD of Aminoglycosides

